Entamoeba coli is an intestinal amoeba, not the bacterium Escherichia coli. The shared abbreviation “E. coli” can cause confusion, but these are very different organisms. CDC generally considers Entamoeba coli nonpathogenic.
On this page
Three names that should not be confused
Entamoeba coli is a protozoan that can colonize the large intestine. Escherichia coli is a bacterium with both harmless and disease-causing types. Entamoeba histolytica is a different amoeba associated with amebiasis. Read the full genus and species before looking up a result. [1]
What GI-MAP reports
GI-MAP includes an Entamoeba coli DNA target in its parasite section. Detection does not establish a Shiga toxin-producing E. coli infection, and it is not evidence of E. histolytica. Neither the number nor the broad heading “parasites” changes those distinctions. [2]
What detection can and cannot explain
As with other nonpathogenic intestinal amoebae, its presence may reflect fecal exposure. It cannot identify a particular source or prove that the organism caused ongoing diarrhea. [1]
Symptoms still need assessment when persistent or severe. The clinician may look for another pathogen or a noninfectious cause rather than stopping at a nonpathogenic finding. A negative Entamoeba coli result also does not rule out every amoeba or bacterial E. coli pathotype.
How to discuss a confusing report
Bring the full page rather than saying only “I tested positive for E. coli.” Include the method and collection date. That small step prevents a harmless-name overlap from being interpreted as a completely different infection.
Common questions
Does this result mean food poisoning from E. coli?
No. Entamoeba coli is not Escherichia coli, and the result does not identify bacterial toxins.
Does it automatically require antiparasitic treatment?
No. A clinician should evaluate the actual illness; detection of a generally nonpathogenic amoeba alone does not establish a treatment need.
Sources and review
Sources checked October 7, 2026. Manufacturer material describes the test; clinical guidance and research support the interpretation limits.
- CDC DPDx: Nonpathogenic intestinal amoebae
- Diagnostic Solutions Laboratory: GI-MAP interpretive guide (manufacturer specifications)
Medical review of this article is pending. For a correction or source question, contact GI MAP Test.